phenytoin has been researched along with sulfamethoxazole in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (33.33) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Boëthius, G; Sjöqvist, F | 1 |
| Craig, WA; Evenson, MA; Sarver, KP; Wagnild, JP | 1 |
| Dasgupta, A; Dean, R; Dennen, DA; McLawhon, RW | 1 |
| Debreczeni, LA; Herjavecz, I; Szeitz, A | 1 |
| Baird, BJ; De Villez, RL | 1 |
| Gillman, MA; Sandyk, R | 1 |
| Jatlow, P | 1 |
| Wilcox, JB | 1 |
| Bishop, E; Chen, FC; Iqbal, K; Malick, AW; Tarantino, R | 1 |
| Beharcohen, F; Dighiero, P; Moussala, M; Renard, G | 1 |
| Malkiewicz, IM; Neuman, MG; Shear, NH | 1 |
| Choquet-Kastylevsky, G; Descotes, J; Faure, L; Ravel, G; Ruat, C | 1 |
| Nierkens, S; Nieuwenhuijsen, L; Pieters, R; Thomas, M | 1 |
| Funabashi, H; Kimura, J; Miyawaki, I; Tamura, A; Yamada, T | 1 |
| Aga, DS; Ernstoff, AS; Love, NG; Moline, CJ; Stadler, LB; Su, L | 1 |
| Hu, C; Li, YY; Nie, Y; Zhang, L | 1 |
24 other study(ies) available for phenytoin and sulfamethoxazole
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Doses and dosage intervals of drugs--clinical practice and pharmacokinetic principles.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Antidepressive Agents, Tricyclic; Child; Digoxin; Drug Administration Schedule; Drug Prescriptions; Humans; Kidney; Kinetics; Middle Aged; Nitrofurantoin; Pharmaceutical Preparations; Phenytoin; Sulfamethoxazole; Sulfonamides; Sweden; Tetracyclines; Trimethoprim | 1978 |
Letter: Potentiations of warfarin by co-trimoxazole.
Topics: Drug Synergism; Humans; Phenytoin; Prothrombin Time; Sulfamethoxazole; Trimethoprim; Warfarin | 1975 |
Correction of protein binding defect in uremic sera by charcoal treatment.
Topics: Blood Proteins; Charcoal; Dicloxacillin; Digitoxin; Fatty Acids, Nonesterified; Humans; In Vitro Techniques; Penicillin G; Phenytoin; Protein Binding; Renal Dialysis; Salicylates; Serum Albumin; Sulfamethoxazole; Uremia | 1976 |
Displacement of phenytoin from serum protein carriers by antibiotics: studies with ceftriaxone, nafcillin, and sulfamethoxazole.
Topics: Carrier Proteins; Ceftriaxone; Drug Interactions; False Negative Reactions; Humans; Nafcillin; Phenytoin; Serum Albumin; Sulfamethoxazole | 1991 |
Effects of drugs on aminophylline elimination in rats.
Topics: Aminophylline; Animals; Behavior, Animal; Carbamazepine; Cimetidine; Drug Combinations; Drug Interactions; Erythromycin; Female; Half-Life; Phenobarbital; Phenytoin; Rats; Rats, Inbred Strains; Rifampin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Widespread bullous fixed drug eruption mimicking toxic epidermal necrolysis.
Topics: Adult; Anti-Infective Agents; Diagnosis, Differential; Drug Combinations; Female; Humans; Male; Phenytoin; Skin Diseases, Vesiculobullous; Stevens-Johnson Syndrome; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Phenytoin toxicity and co-trimoxazole.
Topics: Child, Preschool; Drug Combinations; Drug Interactions; Female; Humans; Phenytoin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Ultraviolet spectrophotometric analysis of barbiturates: evaluation of potential interferences.
Topics: Acetaminophen; Barbiturates; Chlorothiazide; Chlorpropamide; Dicumarol; Humans; Methods; Nicotinic Acids; Oxyphenbutazone; Phenacetin; Phenindione; Phenobarbital; Phenylbutazone; Phenytoin; Salicylates; Spectrophotometry, Ultraviolet; Sulfamethoxazole; Sulfinpyrazone; Sulfisoxazole; Theobromine; Theophylline; Warfarin | 1973 |
Phenytoin intoxication and cotrimoxazole.
Topics: Adult; Drug Combinations; Drug Interactions; Epilepsy; Humans; Male; Phenytoin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1981 |
N-methyl-2-pyrrolidone as a cosolvent: relationship of cosolvent effect with solute polarity and the presence of proton-donating groups on model drug compounds.
Topics: Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Digoxin; Hydrocortisone; Phenytoin; Protons; Pyrrolidinones; Reserpine; Solvents; Spectrophotometry, Ultraviolet; Sulfamethoxazole; Theophylline; Water | 1994 |
[Lyell's syndrome and its ophthalmologic manifestations in Cameroon].
Topics: Adolescent; Adult; Anti-Infective Agents; Anticonvulsants; Blindness; Cameroon; Child; Child, Preschool; Conjunctival Diseases; Conjunctivitis; Dry Eye Syndromes; Eye Diseases; Eyelid Diseases; Female; Follow-Up Studies; Humans; Male; Phenytoin; Stevens-Johnson Syndrome; Sulfadoxine; Sulfamethoxazole; Time Factors; Tissue Adhesions | 2000 |
A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes.
Topics: Adolescent; Adult; Aged; Animals; Anticonvulsants; Carbamazepine; Case-Control Studies; Cell Survival; Chemistry, Clinical; Child; Cohort Studies; Coloring Agents; Drug Hypersensitivity; Family Health; Female; HIV Seropositivity; Humans; Lamotrigine; Lymphocytes; Male; Mice; Microsomes, Liver; Middle Aged; Mitochondria; Phenobarbital; Phenytoin; Sensitivity and Specificity; Succinate Dehydrogenase; Sulfadiazine; Sulfamethoxazole; Sulfonamides; Tetrazolium Salts; Thiazoles; Time Factors; Triazines; Trimethoprim; Trypan Blue | 2000 |
Tritiated thymidine incorporation does not enhance sensitivity of the popliteal lymph node assay.
Topics: Animals; Drug Evaluation, Preclinical; Female; Local Lymph Node Assay; Lymph Nodes; Male; Metformin; Mice; Mice, Inbred BALB C; Ofloxacin; Phenobarbital; Phenytoin; Random Allocation; Streptozocin; Sulfamethoxazole; Thymidine; Tritium | 2003 |
Evaluation of the use of reporter antigens in an auricular lymph node assay to assess the immunosensitizing potential of drugs.
Topics: Animals; Antigens; B-Lymphocytes; Drug Evaluation, Preclinical; Ear, External; Female; Ficoll; Immunization; Immunosuppressive Agents; Injections, Intradermal; Injections, Subcutaneous; Interferon Type I; Interferon-gamma; Local Lymph Node Assay; Lymph Nodes; Mice; Mice, Inbred BALB C; Ofloxacin; Ovalbumin; Phenytoin; Sulfamethoxazole; T-Lymphocytes | 2004 |
Oral administration of drugs with hypersensitivity potential induces germinal center hyperplasia in secondary lymphoid organ/tissue in Brown Norway rats, and this histological lesion is a promising candidate as a predictive biomarker for drug hypersensiti
Topics: Administration, Oral; Amoxicillin; Animals; Biomarkers; Carbamazepine; Drug Hypersensitivity; Flow Cytometry; Germinal Center; Hyperplasia; Immunoglobulin E; Lymphoid Tissue; Phenytoin; Rats; Rats, Inbred BN; Sulfamethoxazole | 2013 |
Effect of redox conditions on pharmaceutical loss during biological wastewater treatment using sequencing batch reactors.
Topics: Aerobiosis; Anaerobiosis; Atenolol; Biological Oxygen Demand Analysis; Bioreactors; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Nitrogen; Oxidation-Reduction; Oxygen; Pharmaceutical Preparations; Phenytoin; Sewage; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Waste Disposal, Fluid; Water Pollutants, Chemical | 2015 |
Enhanced Fenton-like degradation of refractory organic compounds by surface complex formation of LaFeO(3) and H(2)O(2).
Topics: 2,4-Dichlorophenoxyacetic Acid; Acyclovir; Antipyrine; Catalysis; Chlorophenols; Hydrogen Peroxide; Oxides; Phenytoin; Sulfamethoxazole; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2015 |